The detailed analysis, including subgroup breakdowns, long-term safety data, and secondary endpoints, takes additional months to compile
doi:10.1056/NEJMoa2301972 Sanyal AJ, Kaplan LM, Frias JP, et al
By engaging all three receptors simultaneously, retatrutide aims to suppress appetite, regulate blood sugar levels and increase the body's metabolic rate and help increase energy expenditure and influence fat metabolism, though the exact contribution of each pathway is still being studied
Prior Presentation: This work was presented in part at the 2025 International Society for Pharmacoepidemiology (ISPE) Annual Meeting held 2226 August in Washington, DC, USA
Long-term inflammation is linked to: Type 2 diabetes Heart disease Fatty liver (NAFLD/NASH) Obesity Autoimmune and gut disorders Experts believe metabolic inflammation is a root cause of insulin resistance and poor cardiovascular outcomes
Mikki gives Retatrutide to grown-ups who have a BMI of 30 or more